US4218474A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Derivatives of L- and DL-4-hydroxyphenylglycine
Assignee: Pfizer Inc
•
Filing: 1978-10-30
•
Granted: 1980-08-19
•
Expires: 1998-10-30
Abstract
Abstract L- and DL-isomers of compounds of the formula ##STR1## and the pharmaceutically acceptable salts thereof, wherein R is hydrogen or methyl; R 1 is alkynyl, alkenyl or cycloalkyl, each having from three to seven carbon atoms or alkyl having from one to six carbon atoms which may optionally be substituted by one or more groups selected from hydroxy, alkoxy, carboxy, amino, monoalkylamino, dialkylamino, phenyl and phenoxy, any such phenyl or phenoxy being optionally substituted with one or more hydroxy, alkyl or alkoxy groups, said alkyl and alkoxy optional substituents having from one to six carbon atoms; provided that R 1 is other than 4-hydroxy-α-carboxybenzyl or 4-methoxy-α-carboxybenzyl. Said compounds are useful in treating diseases and conditions characterized by reduced blood flow, oxygen availability or carbohydrate metabolism in the cardiovascular system. The D-isomers of the compounds of formula (II) are substantially inactive in treating such diseases and conditions.
Inventors
- 👤 Ian T. Barnish
- 👤 Peter E. Cross
- 👤 John C. Danilewicz
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 13:00
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/06; C07K5/06008; C07K5/06078; A; A61; A61P; A61P3/00; A61P3/08; A61P9/00; A61P9/08; A61P9/10
Claims Analysis
Total Claims: 23
Claim 1
Independent Claim
216 words
L- and DL-isomers of a compound of the formula ##STR22## and the pharmaceutically acceptable salts thereof, wherein R is hydrogen or methyl; R 1 is a member selected from the group consisting of alkynyl, alkenyl, cycloalkyl, each having from three to seven carbon atoms, alkyl having from one to six carbon atoms, CH 2 COOH, (CH 2 ) n NR 2 R 3 , CH 2 C 6 H 3 R 4 R 5 , ##STR23## dihydroxyalkyl having from three to four carbon atoms wherein said hydroxy groups are attached to different carbon atoms, and alkyl having from two to six carbon atoms substituted by up to two unlike members selected from the group consisting of hydroxy, alkoxy having from one to six carbon atoms, carboxy, C 6 H 3 R 4 R 5 and OC 6 H 3 R 4 R 5 provided that when two of said members are present and are hydroxy and said alkoxy, said members are attached to different carbon atoms; n is 1 to 4, R 2 and R 3 are each hydrogen or alkyl having from one to four carbon atoms; R 4 and R 5 are each hydrogen, hydroxy, alkyl or alkoxy having from one to four carbon atoms; further provided that R 1 is other than ##STR24##
Claim 2
Dependent Claim
216 words
L- and DL-isomers of a compound of the formula ##STR22## and the pharmaceutically acceptable salts thereof, wherein R is hydrogen or methyl; R 1 is a member selected from the group consisting of alkynyl, alkenyl, cycloalkyl, each having from three to seven carbon atoms, alkyl having from one to six carbon atoms, CH 2 COOH, (CH 2 ) n NR 2 R 3 , CH 2 C 6 H 3 R 4 R 5 , ##STR23## dihydroxyalkyl having from three to four carbon atoms wherein said hydroxy groups are attached to different carbon atoms, and alkyl having from two to six carbon atoms substituted by up to two unlike members selected from the group consisting of hydroxy, alkoxy having from one to six carbon atoms, carboxy, C 6 H 3 R 4 R 5 and OC 6 H 3 R 4 R 5 provided that when two of said members are present and are hydroxy and said alkoxy, said members are attached to different carbon atoms; n is 1 to 4, R 2 and R 3 are each hydrogen or alkyl having from one to four carbon atoms; R 4 and R 5 are each hydrogen, hydroxy, alkyl or alkoxy having from one to four carbon atoms; further provided that R 1 is other than ##STR24##
Claim 3
Dependent Claim
9 words
The L-isomer of the compounds according to claim 1.
Claim 4
Dependent Claim
10 words
A compound according to claim 2 wherein R is hydrogen.
Claim 5
Dependent Claim
25 words
A compound according to claim 3 wherein R 1 is a member selected from the group consisting of 4-hydroxybenzyl, 2-methoxyethyl, isopropyl, propargyl, cyclopentyl and 2-diethylaminoethyl.
Claim 6
Dependent Claim
7 words
The compound according to claim 1: L-N-(4-hydroxybenzyl)-2-amino-2-(4-hydroxyphenyl)acetamide.
Claim 7
Dependent Claim
7 words
The compound according to claim 1: L-N-(2-methoxyethyl)-2-amino-2-(4-hydroxyphenyl)acetamide.
Claim 8
Dependent Claim
7 words
The compound according to claim 1: L-N-isopropyl-2-amino-2-(4-hydroxyphenyl)acetamide.
Claim 9
Dependent Claim
7 words
The compound according to claim 1: L-N-propargyl-2-amino-2-(4-hydroxyphenyl)acetamide.
Claim 10
Dependent Claim
7 words
The compound according to claim 1: L-N-cyclopentyl-2-amino-2-(4-hydroxyphenyl)acetamide.
Claim 11
Dependent Claim
7 words
The compound according to claim 1: L-N-(2-diethylamino)ethyl-2-amino-2-(4-hydroxyphenyl)acetamide.
Claim 12
Independent Claim
248 words
A method of treating a mammaliam subject suffering from a disease or condition attributable to reduced blood flow or oxygen availability which comprises orally or parenterally administering to said subject a blood flow or oxygen availability increasing amount of an L- or DL-isomer of a compound of the formula ##STR25## and the pharmaceutically acceptable salts thereof, wherein R is hydrogen or methyl; R 1 is a member selected from the group consisting of alkynyl, alkenyl, cycloalkyl, each having from three to seven carbon atoms, CH 2 COOH, (CH 2 ) n NR 2 R 3 , CH 2 C 6 H 3 R 4 R 5 , ##STR26## dihydroxyalkyl having from three to four carbon atoms wherein said hydroxy groups are attached to different carbon atoms, and alkyl having from two to six carbon atoms substituted by up to two unlike members selected from the group consisting of hydroxy, alkoxy having from one to six carbon atoms, carboxy, C 6 H 3 R 4 R 5 and OC 6 H 3 R 4 R 5 provided that when two of said members are present and are hydroxy and said alkoxy, said members are attached to different carbon atoms; n is 1 to 4, R 2 and R 3 are each hydrogen or alkyl having from one to four carbon atoms; R 4 and R 5 are each hydrogen, hydroxy, alkyl or alkoxy having from one to four carbon atoms; further provided that R 1 is other than ##STR27##
Claim 13
Independent Claim
248 words
A method of treating a mammaliam subject suffering from a disease or condition attributable to reduced blood flow or oxygen availability which comprises orally or parenterally administering to said subject a blood flow or oxygen availability increasing amount of an L- or DL-isomer of a compound of the formula ##STR25## and the pharmaceutically acceptable salts thereof, wherein R is hydrogen or methyl; R 1 is a member selected from the group consisting of alkynyl, alkenyl, cycloalkyl, each having from three to seven carbon atoms, CH 2 COOH, (CH 2 ) n NR 2 R 3 , CH 2 C 6 H 3 R 4 R 5 , ##STR26## dihydroxyalkyl having from three to four carbon atoms wherein said hydroxy groups are attached to different carbon atoms, and alkyl having from two to six carbon atoms substituted by up to two unlike members selected from the group consisting of hydroxy, alkoxy having from one to six carbon atoms, carboxy, C 6 H 3 R 4 R 5 and OC 6 H 3 R 4 R 5 provided that when two of said members are present and are hydroxy and said alkoxy, said members are attached to different carbon atoms; n is 1 to 4, R 2 and R 3 are each hydrogen or alkyl having from one to four carbon atoms; R 4 and R 5 are each hydrogen, hydroxy, alkyl or alkoxy having from one to four carbon atoms; further provided that R 1 is other than ##STR27##
Claim 14
Dependent Claim
12 words
A method according to claim 11 wherein said compound is the L-isomer.
Claim 15
Dependent Claim
10 words
A method according to claim 12 wherein R is hydrogen.
Claim 16
Dependent Claim
25 words
The method according to claim 13 wherein R 1 is a member selected from the group consisting of 4-hydroxybenzyl, 2-methoxyethyl, isopropyl, propargyl, cyclopentyl and 2-diethylaminoethyl.
Claim 17
Dependent Claim
23 words
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a blood flow or oxygen availability increasing amount of a compound of claim 1.
Claim 18
Independent Claim
242 words
A method of treating a mammaliam subject suffering from a disease or condition attributable to reduced carbohydrate metabolism which comprises orally or parenterally administering to said subject a carbohydrate metabolism increasing about of an L- or DL-isomer of a compound of the formula ##STR28## and the pharmaceutically acceptable salts thereof, wherein R is hydrogen or methyl; R 1 is a member selected from the group consisting of alkynyl, alkenyl, cycloalkyl, each having from three to seven carbon atoms, CH 2 COOH, (CH 2 ) n NR 2 R 3 , CH 2 C 6 H 3 R 4 R 5 , ##STR29## dihydroxyalkyl having from three to four carbon atoms wherein said hydroxy groups are attached to different carbon atoms, and alkyl having from two to six carbon atoms substituted by up to two unlike members selected from the group consisting of hydroxy, alkoxy having from one to six carbon atoms, carboxy, C 6 H 3 R 4 R 5 and OC 6 H 3 R 4 R 5 provided that when two of said members are present and are hydroxy and said alkoxy, said members are attached to different carbon atoms; n is 1 to 4, R 2 and R 3 are each hydrogen or alkyl having from one to four carbon atoms; R 4 and R 5 are each hydrogen, hydroxy, alkyl or alkoxy having from one to four carbon atoms; further provided that R 1 is other than ##STR30##
Claim 19
Independent Claim
242 words
A method of treating a mammaliam subject suffering from a disease or condition attributable to reduced carbohydrate metabolism which comprises orally or parenterally administering to said subject a carbohydrate metabolism increasing about of an L- or DL-isomer of a compound of the formula ##STR28## and the pharmaceutically acceptable salts thereof, wherein R is hydrogen or methyl; R 1 is a member selected from the group consisting of alkynyl, alkenyl, cycloalkyl, each having from three to seven carbon atoms, CH 2 COOH, (CH 2 ) n NR 2 R 3 , CH 2 C 6 H 3 R 4 R 5 , ##STR29## dihydroxyalkyl having from three to four carbon atoms wherein said hydroxy groups are attached to different carbon atoms, and alkyl having from two to six carbon atoms substituted by up to two unlike members selected from the group consisting of hydroxy, alkoxy having from one to six carbon atoms, carboxy, C 6 H 3 R 4 R 5 and OC 6 H 3 R 4 R 5 provided that when two of said members are present and are hydroxy and said alkoxy, said members are attached to different carbon atoms; n is 1 to 4, R 2 and R 3 are each hydrogen or alkyl having from one to four carbon atoms; R 4 and R 5 are each hydrogen, hydroxy, alkyl or alkoxy having from one to four carbon atoms; further provided that R 1 is other than ##STR30##
Claim 20
Dependent Claim
12 words
A method according to claim 16 wherein said compound is the L-isomer.
Claim 21
Dependent Claim
10 words
A method according to claim 17 wherein R is hydrogen.
Claim 22
Dependent Claim
25 words
A method according to claim 18 wherein R 1 is a member selected from the group consisting of 4-hydroxybenzyl, 2-methoxyethyl, isopropyl, proparagyl, cyclopentyl and 2-diethylaminoethyl.
Claim 23
Dependent Claim
20 words
The pharmaceutical composition comprising a pharmaceutically acceptable carrier and a carbohydrate metabolism increasing amount of a compound of claim 1.
References Cited (Backward Citations)
US2868818A
Cited
US2833764A
Cited
US3725470A
Cited
US4087520A
Cited
US4093653A
Cited
US4111981A
Cited
US4148920A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1983-08-19 | 1984-02-18 | 1984-08-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1987-08-19 | 1988-02-18 | 1988-08-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1991-08-19 | 1992-02-18 | 1992-08-19 | $7700.00 | Window Closed / Lapsed |